Rationale, design, and baseline characteristics of a trial of prevention of cardiovascular and renal disease with fosinopril and pravastatin in nonhypertensive, nonhypercholesterolemic subjects with microalbuminuria (the prevention of REnal and vascular ENdstage disease intervention trial [PREVEND IT])

Publication | Closed Access

DOI

Citations

References

2000

Year

Gilles F.H. Diercks, Wilbert M.T. Janssen, Ad J. van Boven, Annette Bak, Paul E. de Jong, Harry J.G.M. Crijns, Wiek H. van Gilst

The American Journal of Cardiology

Nonhypercholesterolemic SubjectsHypertensionRenal FunctionRenal DiseaseCardiovascular DiseaseMedicineAntihypertensive TherapyChronic Kidney DiseasePharmacotherapyBaseline CharacteristicsPharmacologyAtherosclerosisNephrology